Abstracts tagged "gout and quality of care"

Abstract Number: 210 • 2013 ACR/ARHP Annual Meeting
Medication Adherence In Patients With Gout: A Systematic Review
Mary De Vera^1,2, Sharan Rai¹ and Vidula Bhole³, ¹Arthritis Research Centre of Canada, Richmond, BC, Canada, ²Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ³EpiSolutions Consultancy Services, Thane, India
Background/Purpose: Recent data suggesting the growing problem of medication non-adherence in gout has called for the need to understand the magnitude of the problem as…
Abstract Number: 2041 • 2012 ACR/ARHP Annual Meeting
Improving Access and Patient Education in Rheumatology: the Gout Shared Medical Appointment; a Quality Improvement Initiative
Alicia J. Zbehlik¹ and Nicole M. Orzechowski², ¹Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, ²Section of Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH
Background/Purpose: Patients experience long waits for consultations in Rheumatology at Dartmouth-Hitchcock Medical Center (DHMC). The cause of this is multi-factorial, including provider referral patterns, patient preferences,…
Abstract Number: 1815 • 2012 ACR/ARHP Annual Meeting
Factors Associated with a Prolonged Hospital Length of Stay for Patients with Acute Gout
Rebecca Sharim¹, Meghan Musselman² and Marissa Blum³, ¹Department of Medicine, Temple University Hospital, Philadelphia, PA, ²Temple University School of Medicine, Philadelphia, PA, ³Medicine/Rheumatology, Temple University School of Medicine, Philadelphia, PA
Background/Purpose: Management of gout in the hospital setting has been poor. This study aimed to describe patient characteristics and the treatment patterns of acute gout…
Abstract Number: 149 • 2012 ACR/ARHP Annual Meeting
Natural Language Processing in the Evaluation of Gout Quality Indicators
Gail S. Kerr¹, J. Steuart Richards², Carl A. Nunziato³, Olga V. Patterson⁴, Scott L. DuVall⁵, David D. Maron⁶ and Richard L. Amdur⁷, ¹Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, ²Rheumatology, Washington DC VA and Georgetown University, Washington, DC, ³Rheumatology, Washington DC VA and Howard University, Washington, DC, ⁴VA Salt Lake City Health Care System and University of Utah School of Medicine, UT, ⁵VA Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ⁶Research Department, Washington DC VA Medical Center, Washington, DC, ⁷Washington DC VA and Georgetown Unviversity, Washington, DC
Background/Purpose: Gout is a common inflammatory arthritis with significant impact on both patients and health care systems. Despite ACR/EULAR management guidelines and gout quality indicators…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].